A human bone morphogenetic protein antagonist is down-regulated in renal cancer - Wikidata - awgldk - TriplyDB

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

http://www.wikidata.org/entity/Q36438780

about

Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.Update on Wnt signaling in bone cell biology and bone disease.Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2 Secreted and transmembrane wnt inhibitors and activators.SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression.Serum sclerostin levels in renal cell carcinoma patients with bone metastases Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals.The complex roles of Wnt antagonists in RCC.Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells Hepcidin regulation in prostate and its disruption in prostate cancer.Agonists and Antagonists of TGF-β Family Ligands.In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest.Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes.Bone morphogenetic protein signaling: implications in urology.Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men.Mechanistic basis for the chemopreventive effects of black raspberries at a late stage of rat esophageal carcinogenesis.Population-specific genetic modification of Huntington's disease in Venezuela.SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin

P2860

Q33597062-998FF497-A808-4D0B-8B0D-A84E14DA65C6 Q34408171-C23F6B59-EFC1-41F1-B5B3-2D592EA10A74 Q36035290-3ED5A4B6-6F72-4F5F-8FB4-AB5B0BA8C9DF Q36083303-06DB2C14-FFBD-469F-9A98-5591DF6E169C Q36544687-09F047B8-2E4E-4EC8-BE54-05C66B978C6D Q36626700-AE2EB7D1-D30E-434A-A8E4-3E44E1B96C0E Q36800327-AB7B3EB4-73B8-46C5-B1EF-0CC9DB4C2987 Q36936190-5737C071-3997-49FD-A57D-B2D64FB976AE Q37234857-2B73463C-A5F4-4651-8D22-1DA8B3AE8389 Q37282121-84D9EC55-B4C5-4D1A-82C4-10ACDF111677 Q37371753-82055230-C8E8-432B-B09F-69E76FACEE69 Q37949269-B910F415-D753-47E4-B61A-530FB44A4408 Q38153283-067794F2-DB20-4CB3-AEF9-720460750978 Q38233800-8907C662-6130-4311-B603-0B899A7312BB Q38889135-C69C3545-991E-4EBF-9F79-197606525CCE Q38896053-061B73AF-8EDC-4CCA-B410-CBCD97127F04 Q39188239-4373C35A-5E6A-409A-A95E-0A7C283097BC Q39242337-222BFBA8-DD31-47BB-B405-D55EA417DEE4 Q39935350-7844DE72-9AF1-4680-BF61-59F16D907CED Q40726927-57117118-F90A-40B8-B523-95B7AEBF054B Q41783158-F7FD7CA6-81B5-4376-8714-25110B14F811 Q49389245-0F7E1F8A-3ED2-46AB-84A5-006B58B5CA8C Q51518471-7B8C16D6-479F-46F9-AA1D-5AC981C990D6 Q53288332-D3CF5558-1EE7-4FC6-8A96-262A34E7C39B Q55020670-2E1A69A3-5315-4455-8226-E8FAC7081BD4 Q57478262-9F71BBB4-F782-4353-A06C-3D4E51B0AEB2 Q58700293-96477E71-DA7C-48AB-8FA1-21741850DF5D

P2860

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

http://www.wikidata.org/entity/Q36438780

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@ast

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@en

type

label

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@ast

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@en

prefLabel

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@ast

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@en

P1433

Q36438780-8DAA43E6-D620-47D4-9A5C-6A0CFFA547BD

P1476

Q36438780-10902DD9-813E-402F-84C3-4C87BD506CDE

P2093

Q36438780-1012334E-9D7D-40BF-9DD9-A0BA4C5B7616

Q36438780-11F9E458-5C61-4B8D-B4DA-EF8FC273E276

Q36438780-13D3ECDE-D9F3-4BC6-8BBA-CB640D5A84C6

Q36438780-2A10F834-F14F-4DFB-8E35-D5BA72E1751F

Q36438780-5941C9A8-7533-4AAF-AF15-20ED299E09B5

Q36438780-5F15F325-7402-4C8D-9A58-AADC0AF83BDD

Q36438780-7AAC5211-A810-4B7D-B968-83CE329C936F

Q36438780-81813530-9B76-4863-89A5-0C62EA1E1EDB

Q36438780-A0DD6D94-F00D-4A47-9222-9B101C8F3A5C

Q36438780-DEBF3014-38DE-4C47-9F33-A5AB813429CF

P2860

Q36438780-024D82BF-B1A3-4B9F-93D2-FBBA4FE35CB0

Q36438780-1419D00F-28A9-4207-B6D1-C8C90E5E11DE

Q36438780-1E357097-4C6D-4493-91F4-F9321AF2CDF3

Q36438780-236963EA-72D5-4AAE-9087-5BF83886CAFE

Q36438780-24AE6480-A073-4A18-9502-593DBE1017B8

Q36438780-26F222A1-B428-4BD8-A3AE-CE86476856AB

Q36438780-2F6F08D5-1AD8-44D6-9502-D65EB6C7D48A

Q36438780-3136A378-5C3C-474F-B9EA-64AAD7531992

Q36438780-36AB056A-101B-41B3-A09C-3A5773C6FADF

Q36438780-39037D23-C17A-453F-81A3-79623E2B6E20

P304

Q36438780-FA2AC9AF-EED9-4B77-843D-A345C38F0D8C

P31

Q36438780-20723652-91CB-4AC7-B69E-1921D3E10E56

P356

Q36438780-F2D25F05-696D-41CB-B4CC-5B646B476B22

P433

Q36438780-883E20B6-81FE-42E4-B622-2687683BAF25

P478

Q36438780-8AAEF3E7-D69F-4CA9-A1D8-5AED9759DBFC

P577

Q36438780-D6031322-DA4B-4AF3-8153-A37BA757B7A3

P698

Q36438780-3C3ED977-2B81-4643-B79B-B1A5B240F4A1

P921

Q36438780-1388640D-07F5-4027-8CE0-4CAFD1B4D5B8

P932

Q36438780-3298C2F4-86CE-4606-8DA9-7C2C366EB047

P356

MBC.E07-05-0433

P1433

Molecular Biology of the Cell

P1476

A human bone morphogenetic protein antagonist is down-regulated in renal cancer

@en

P2093

A Julian Garvin

http://www.w3.org/2001/XMLSchema#string

Charles E Birse

http://www.w3.org/2001/XMLSchema#string

Frank M Torti

http://www.w3.org/2001/XMLSchema#string

Gregory A Hawkins

http://www.w3.org/2001/XMLSchema#string

Julie C Brown

http://www.w3.org/2001/XMLSchema#string

Kimberly Rose Blish

http://www.w3.org/2001/XMLSchema#string

Mark C Willingham

http://www.w3.org/2001/XMLSchema#string

Ralph B D'Agostino

http://www.w3.org/2001/XMLSchema#string

Surekha R Krishnan

http://www.w3.org/2001/XMLSchema#string

Suzy V Torti

http://www.w3.org/2001/XMLSchema#string

P2860

Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling

TGF-beta signaling by Smad proteins

Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot

Smad regulation in TGF-beta signal transduction

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney

Bone: formation by autoinduction

BMP antagonists: their roles in development and involvement in pathophysiology

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation

Bone morphogenetic proteins

P304

457-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1091/MBC.E07-05-0433

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18032587

http://www.w3.org/2001/XMLSchema#string

P921

P932

2230586

http://www.w3.org/2001/XMLSchema#string